Arkolith/Insider Trading/VCEL/Form 4

Hopper Jonathan Mark

Chief Medical OfficerVericel Corp (VCEL) · full profile →Form 4 · filed Jun 4, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$153K
Net Open-Market Flow
-$153K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 2, 2026Option exercise(M)4K$16.66$73K80K
Jun 2, 2026Sell(S)4K$35.00$153K76K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 2, 2026Option exercise(M)4K—$02K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-26-023988) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Vericel Corp

Build

Ask your agent about VCEL insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001140361-26-023988"
Ask your agent
Use Arkolith to summarize insider buying and selling at Vericel Corp
over the last 90 days and cite the filings.